Form D · Pharmaceuticals
Evrys Bio, LLC
Doylestown, PA · CIK 0001597945
Offering snapshot reported Jan 5, 2022 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 1, 2017 | Amendment | $3,367,867 | $3,020,367vs Mar 15, 2016 | 18 | SEC filing |
| Mar 15, 2016 | Initial | $347,500 | No comparison | 4 | SEC filing |
| Jan 22, 2014 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-428005
Source: Form D, filed Jan 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lillian Chiang | Director, Executive |
| Steve Holtzman | Director |
| Steven Holtzman | Director |
| Brian W. Pusch | Director |
| Thomas Shenk | Director, Executive |
| Richard Whitley | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3805 Old Easton Road
Doylestown, PA, 18902
Doylestown, PA, 18902